CP-181 Profile of use of a mucositis compounded suspension in patients affected with mucositis
CP-181 Profile of use of a mucositis compounded suspension in patients affected with mucositis
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundMucositis is one of the most frequent complications in patients receiving chemotherapy. Currently there is no standard treatment, and its management is essentially based on adequate oral hygiene and mouthwashes. In our hospital, the pharmacy department compounds an oral suspension of 250 ml of sodium bicarbonate 3.5 g, gentamycin 47 mg, h...
Alternative Titles
Full title
CP-181 Profile of use of a mucositis compounded suspension in patients affected with mucositis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2552750436
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552750436
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2016-000875.181
